Skip to main content

Tharimmune, Inc.

For the period ended Feb 5, 2026. Filed Feb 6, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Feb 5, 2026 · Filed Feb 6, 2026

Use the contents to explore the available documents and sections.

CNTN$2.06+6.7%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Forward-Looking Statements

The information set forth in this Current Report on Form 8-K (“Current Report”), including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

Item 9.01Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.Description of Exhibit
10.1#Employment Agreement with Angela Dominy Radkowski, dated February 5, 2026
99.1Press Release, dated February 6, 2026
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
#Indicates a management contract or any compensatory plan, contract or arrangement.

-3-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.